Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

6,825 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development and Application of an Active Pharmacovigilance Framework Based on Electronic Healthcare Records from Multiple Centers in Korea.
Choe S, Lee S, Park CH, Lee JH, Kim HJ, Byeon SJ, Choi JH, Yang HJ, Sim DW, Cho BJ, Koo H, Kang MG, Jeong JB, Choi IY, Kim SH, Kim WJ, Jung JW, Lhee SH, Ko YJ, Park HK, Kang DY, Kim JH. Choe S, et al. Among authors: choi jh, choi iy. Drug Saf. 2023 Jul;46(7):647-660. doi: 10.1007/s40264-023-01296-2. Epub 2023 May 27. Drug Saf. 2023. PMID: 37243963
Severe Cutaneous Adverse Reactions to Antiepileptic Drugs: A Nationwide Registry-Based Study in Korea.
Park CS, Kang DY, Kang MG, Kim S, Ye YM, Kim SH, Park HK, Park JW, Nam YH, Yang MS, Jee YK, Jung JW, Kim SH, Kim CW, Kim MY, Kim JH, Lee J, Lee JG, Kim SH, La HO, Kim MH, Park SJ, Koh YI, Lee SM, Kwon YE, Jin HJ, Kim HK, Kang HR, Choi JH; Korean Registry of Severe Cutaneous Adverse Reactions Consortium. Park CS, et al. Among authors: choi jh. Allergy Asthma Immunol Res. 2019 Sep;11(5):709-722. doi: 10.4168/aair.2019.11.5.709. Allergy Asthma Immunol Res. 2019. PMID: 31332981 Free PMC article.
A Randomized, Noninferiority Trial Comparing ICS + LABA with ICS + LABA + LAMA in Asthma-COPD Overlap (ACO) Treatment: The ACO Treatment with Optimal Medications (ATOMIC) Study.
Park SY, Kim S, Kim JH, Kim SH, Lee T, Yoon SY, Kim MH, Moon JY, Yang MS, Jung JW, Kim JH, Choi JH, Park CS, Kim S, Lee J, Kwon JW, Hur GY, Kim SH, Kim HK, Shin YS, Kim SH, Nam YH, Jang AS, Park SY, Kim TB; Cohort for Reality and Evolution of Adult Asthma in Korea (COREA) Study Group. Park SY, et al. Among authors: choi jh. J Allergy Clin Immunol Pract. 2021 Mar;9(3):1304-1311.e2. doi: 10.1016/j.jaip.2020.09.066. Epub 2020 Nov 9. J Allergy Clin Immunol Pract. 2021. PMID: 33184024 Clinical Trial.
Severe Cutaneous Adverse Reactions to Anti-tuberculosis Drugs in Korean Patients.
Jin HJ, Kang DY, Nam YH, Ye YM, Koh YI, Hur GY, Kim SH, Yang MS, Kim S, Jeong YY, Kim MH, Choi JH, Kang HR, Jo EJ, Park HK; Korean Severe Cutaneous Adverse Reactions Consortium (KoSCAR). Jin HJ, et al. Among authors: choi jh. Allergy Asthma Immunol Res. 2021 Mar;13(2):245-255. doi: 10.4168/aair.2021.13.2.245. Allergy Asthma Immunol Res. 2021. PMID: 33474859 Free PMC article.
Selenomonas: A marker of asthma severity with the potential therapeutic effect.
Kim YC, Choi S, Sohn KH, Bang JY, Kim Y, Jung JW, Kim HY, Park J, Kim K, Kang MG, Yang MS, Kim S, Kim SH, Choi JH, Park HJ, Lee SM, Kim SH, Park JW, Lee JM, Cho SH, Won S, Yi H, Kang HR. Kim YC, et al. Among authors: choi jh, choi s. Allergy. 2022 Jan;77(1):317-320. doi: 10.1111/all.15114. Epub 2021 Oct 20. Allergy. 2022. PMID: 34587325 No abstract available.
6,825 results